This analysis examines the current position and future outlook for Genzyme in the biotechnology sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.

• Benchmark Genzyme's performance against key rivals in the biotechnology sector
• Understand the impact of Genzyme's M&A strategy